0000000000623674

AUTHOR

Anna L.v. Johansson

showing 1 related works from this author

6P 25-year survival and benefit from tamoxifen therapy by the clinically used breast cancer markers in lymph node-negative and ER-positive/HER2-negat…

2021

Oncologymedicine.medical_specialtyBreast cancerOncologybusiness.industryInternal medicineHER2 negativemedicineTamoxifen therapyHematologyLymph node negativemedicine.diseasebusinessAnnals of Oncology
researchProduct